Insulin signaling is robustly activated in human glioma cells independently of insulin stimulation, since the catalytic subunit of the InsR strongly phosphorylates and recruits IRS-1 leading to the activation of AKT and ERK2 (41) (Figure 1A). The gene discussed is AKT1; the disease is central nervous system cancer.